Hoth Therapeutics achieves European regulatory milestone for HT-001

Zydus Lifesciences acquires Agenus Inc's biologics manufacturing facilities, launches Zylidac Bio LLC in US

AVEO Oncology reports first patient dosed in front-line AML combination study of ficlatuzumab

GenomOncology and OHSU Knight Diagnostics Lab partner to enhance clinical trial matching for cancer patients

Rakuten Medical signs manufacturing agreement with LOTTE Biologics

Curasight reports preliminary data from Phase 1 trial in patients with high-grade gliomas

Abbisko Therapeutics reports US FDA acceptance of pimicotinib NDA

AbbVie licenses PD-1/VEGF bispecific antibody RC148 from RemeGen in multi-billion dollar oncology deal

Summit Therapeutics and GSK form collaboration to study ivonescimab combination therapy

Summit Therapeutics submits FDA application for ivonescimab in EGFR-mutated lung cancer

Phanes Therapeutics reports clinical data on spevatamig chemotherapy combination in frontline treatment of mPDAC

Acousia Therapeutics completes patient enrolment in Phase 2 trial of Bimokalner

ZYUS Life Sciences reports positive preliminary results from Phase 2a trial of Trichomylin softgel

DELFI Diagnostics names new chief financial officer

Arbele's ARB1002 receives US FDA Orphan Drug Designation